clindamycin

(redirected from Clindamycin phosphate)
Also found in: Dictionary.

clindamycin

 [klin″dah-mi´sin]
1. a semisynthetic antibiotic that is a derivative of lincomycin; used to treat gram-positive penicillin-resistant infections.
2. a semisynthetic derivative of lincomycin used systemically, topically, and vaginally as an antibacterial, primarily against gram-positive bacteria; used also as the hydrochloride and phosphate salts and as the hydrochloride salt of the ester of clindamycin and palmitic acid (clindamycin palmitate hydrochloride).

clindamycin

/clin·da·my·cin/ (klin″dah-mi´sin) a semisynthetic derivative of lincomycin used systemically, topically, and vaginally as an antibacterial, primarily against gram-positive bacteria; used also as the hydrochloride and phosphate salts and as the hydrochloride salt of the ester of clindamycin and palmitic acid.

clindamycin

(klĭn′də-mī′sĭn)
n.
A semisynthetic antibiotic, C18H33ClN2O5S, derived from lincomycin and active against gram-positive bacteria.

clindamycin

Infectious disease An antibiotic combined with pyrimethamine to treat and prevent toxoplasmosis, PCP and, topically, for acne vulgaris Adverse effects Diarrhea, dysgeusia. See AIDS.

clindamycin

An antibiotic drug that penetrates well into bone to treat OSTEOMYELITIS. The drug is on the WHO official list. Brand names are Dalacin C and, for external use, Dalacin T.

clindamycin

a semisynthetic bacteriostatic antibiotic derivative of lincomycin with improved activity against anaerobic bacteria. It also has some antiprotozoal activity.
References in periodicals archive ?
An aqueous gel fixed combination of clindamycin phosphate 1.
In a study that compared 386 patients applying clindamycin phosphate foam 1% with 385 patients using clindamycin phosphate gel 1%, clindamycin foam reduced total acne lesions by 43%, whereas the gel was associated with a 36% reduction.
Tenders are invited for tender for the supply of clindamycin phosphate 300mg injections ct2083/2017
The Food and Drug Administration has approved Veltin, gel containing clindamycin phosphate and tretinoin, for the topical treatment of acne vulgaris in patients aged 12 years and older.
A 12-week, randomized, investigator-blind, vehicle-controlled, multicenter phase III study compared clindamycin phosphate foam 1% with clindamycin phosphate 1% gel and foam and gel vehicles in 1,026 patients with mild to moderate acne vulgaris.
Several types of combination treatments allow clinicians to target different causes of acne vulgaris, but the safety and efficacy of tretinoin / clindamycin phosphate and salicylic acid / clindamycin phosphate have not previously been compared, according to Dr.
Researchers randomized 46 acne patients aged 18-31 years to one of the two combination therapies: 3% salicylic acid plus clindamycin phosphate 1% lotion (SA/CDP) or all trans retinoic acid 0.
2% clindamycin phosphate significantly reduces both inflammatory and noninflammatory acne lesions, Dr.
2% clindamycin phosphate significantly reduces inflammatory and noninflammatory acne lesions, Dr.
Evoclin (clindamycin phosphate) foam, 1%, which delivers the topical antibiotic clindamycin phosphate.
Comment: In a noninferiority study that compared 386 patients using Evoclin Foam with 385 using clindamycin phosphate gel 1%, Evoclin reduced total acne lesions by 43%, compared with the reference drug's 36% reduction.